Henry Schein, Inc.

XTRA:HS2 Rapport sur les actions

Capitalisation boursière : €8.8b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Henry Schein Résultats passés

Passé contrôle des critères 1/6

Henry Schein has been growing earnings at an average annual rate of 3.3%, while the Healthcare industry saw earnings growing at 15.7% annually. Revenues have been growing at an average rate of 7.3% per year. Henry Schein's return on equity is 9.2%, and it has net margins of 3.5%.

Informations clés

3.3%

Taux de croissance des bénéfices

5.9%

Taux de croissance du BPA

Healthcare Croissance de l'industrie15.7%
Taux de croissance des recettes7.3%
Rendement des fonds propres9.2%
Marge nette3.5%
Dernière mise à jour des bénéfices30 Sep 2023

Mises à jour récentes des performances passées

Recent updates

Ventilation des recettes et des dépenses

Comment Henry Schein gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

XTRA:HS2 Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Sep 2312,6934452,8980
01 Jul 2312,5984582,8330
01 Apr 2312,5284782,8060
31 Dec 2212,6475382,7710
24 Sep 2212,6076382,7320
25 Jun 2212,7186502,7470
26 Mar 2212,6556462,7020
25 Dec 2112,4016312,6340
25 Sep 2112,2366262,5810
26 Jun 2111,8986062,4840
27 Mar 2110,6154382,2940
26 Dec 2010,1194032,0860
26 Sep 209,6225912,1880
27 Jun 209,2915852,2030
28 Mar 2010,0547132,3510
28 Dec 199,9867012,3580
28 Sep 199,7894882,3010
29 Jun 199,6364442,2780
30 Mar 199,5044382,2380
29 Dec 189,4184312,2170
29 Sep 1810,2633042,3190
30 Jun 1811,0693522,3840
31 Mar 1811,8123772,4600
30 Dec 178,8832932,0720
30 Sep 1712,2645542,5040
01 Jul 1711,9685502,4680
01 Apr 1711,7825342,4400
31 Dec 1611,5725072,4090
24 Sep 1611,3024982,3660
25 Jun 1611,1224922,3360
26 Mar 1610,8794892,2960
26 Dec 1510,6304792,2380
26 Sep 1510,4814822,2190
27 Jun 1510,4194692,2150
28 Mar 1510,4054672,2020
27 Dec 1410,3714662,1960
27 Sep 1410,1964572,1470
28 Jun 149,9214502,0790
29 Mar 149,6974422,0250
28 Dec 139,5614321,9790
28 Sep 139,4434201,9480
29 Jun 139,3254091,9290
30 Mar 139,1343991,9010

Des revenus de qualité: HS2 has a large one-off loss of $192.0M impacting its last 12 months of financial results to 30th September, 2023.

Augmentation de la marge bénéficiaire: HS2's current net profit margins (3.5%) are lower than last year (5%).

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: HS2's earnings have grown by 3.3% per year over the past 5 years.

Accélération de la croissance: HS2's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Bénéfices par rapport au secteur d'activité: HS2 had negative earnings growth (-29.6%) over the past year, making it difficult to compare to the Healthcare industry average (-16.1%).

Rendement des fonds propres

ROE élevé: HS2's Return on Equity (9.2%) is considered low.

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé

7D

1Y

7D

1Y

7D

1Y